| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2024 | SERA Sera Prognostics, Inc. | Boniface John J.55 | Chief Scientific Officer | Sell | 5,022 | $7.42 | $37,263.24 | -3.7% | +3.4% | -64.9% | |
| Aug 7, 2024 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 5,022 | $7.42 | $37,263.24 | -3.5% | +3.4% | -64.9% | |
| Aug 7, 2024 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 4,333 | $7.42 | $32,150.86 | -2.3% | +3.4% | -64.9% | |
| Aug 7, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 12,327 | $7.42 | $91,466.34 | -1.4% | +3.4% | -64.9% | |
| Aug 7, 2024 | TMDX Transmedics Group, Inc. | Ranganath Anil P.59 | See Remarks | Sell | 4,992 | $149.81 | $747,838.43 | -22.0% | -43.1% | -20.4% | |
| Aug 6, 2024 | TMDX Transmedics Group, Inc. | Basile Edward M64 | Director | Sell | 6,750 | $149.96 | $1,012,229.66 | -36.2% | -45.6% | -23.9% | |
| Aug 6, 2024 | HOLX Hologic Inc | Schnittker Brandon | Div. President, Gyn Surgical | Sell | 476 | $83.11 | $39,559.41 | -11.3% | +1.5% | -18.9% | |
| Aug 6, 2024 | RPID Rapid Micro Biosystems, Inc. | Kollender Richard S | Director | Buy | 65,000 | $0.77 | $50,128.00 | +204.9% | +38.3% | +336.6% | |
| Aug 6, 2024 | SYK Stryker Corp | Stryker Ronda E57 | Director, 10% Owner | Sell | 190,000 | $323.46 | $61,457,149.31 | -0.6% | +13.7% | +16.2% | |
| Aug 6, 2024 | NEOG Neogen Corp | Tobin James P | Director | Buy | 3,000 | $16.86 | $50,571.00 | +14.7% | -13.9% | -71.5% | |
| Aug 6, 2024 | CVRX Cvrx, Inc. | Slattery Joseph P | Director | Buy | 2,500 | $9.09 | $22,725.00 | +11.3% | +66.3% | -22.0% | |
| Aug 6, 2024 | RPID Rapid Micro Biosystems, Inc. | Spignesi Robert G. Jr.53 | President And CEO | Buy | 50,000 | $0.77 | $38,400.00 | +10.2% | +38.3% | +336.6% | |
| Aug 6, 2024 | UFPT Ufp Technologies Inc | Lataille Ronald J59 | Chief Financial Officer | Sell | 13,064 | $303.82 | $3,969,124.32 | -3.5% | -10.2% | -30.9% | |
| Aug 5, 2024 | LMAT Lemaitre Vascular Inc | Kamke Trent G53 | Senior V. P., Operations | Sell | 182 | $81.82 | $14,891.24 | -3.8% | +19.7% | +6.4% | |
| Aug 5, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 15,458 | $0.99 | $15,252.41 | +0.1% | -28.4% | -27.7% | |
| Aug 5, 2024 | RXST Rxsight, Inc. | Goldshleger Ilya81 | See Remarks | Sell | 9,000 | $39.25 | $353,290.97 | -3.2% | +25.7% | -81.2% | |
| Aug 5, 2024 | BLCO Bausch & Lomb Corp | Saunders Brent L51 | CEO And Chairman Of The Board | Buy | 32,250 | $15.66 | $505,067.25 | +5.7% | +29.0% | -6.2% | |
| Aug 5, 2024 | CVRX Cvrx, Inc. | Hykes Kevin | Pres &CEO | Buy | 30,000 | $8.36 | $250,767.00 | New | +77.9% | -19.6% | |
| Aug 5, 2024 | RMD Resmed Inc | Leong Justin | President, Asia Latin America | Sell | 48,000 | $217.07 | $10,419,552.00 | -71.9% | +12.9% | +32.1% | |
| Aug 5, 2024 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 1,200,000 | $1.62 | $1,948,680.00 | +1.3% | +32.1% | -18.2% | |
| Aug 2, 2024 | LFWD Lifeward Ltd. | Jasinski Lawrence J62 | Chief Executive Officer | Sell | 2,665 | $3.84 | $10,233.60 | -2.5% | -42.1% | -81.7% | |
| Aug 2, 2024 | ATEC Alphatec Holdings, Inc. | Valentine Keith | Director | Buy | 39,000 | $6.55 | $255,450.00 | +90.4% | +24.6% | +118.6% | |
| Aug 2, 2024 | ATEC Alphatec Holdings, Inc. | Demski David M67 | Director | Buy | 40,000 | $6.56 | $262,400.00 | +20.2% | +24.6% | +118.6% | |
| Aug 2, 2024 | CERS Cerus Corp | Benjamin Richard J71 | Chief Medical Officer | Sell | 21,605 | $2.50 | $54,012.50 | -4.7% | -33.0% | -45.8% | |
| Aug 2, 2024 | RGEN Repligen Corp | Kuriyel Ralf72 | Senior VP, R&D | Sell | 7,148 | $159.35 | $1,139,016.03 | -22.5% | -16.9% | -26.4% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.